Neuroprotective tripeptide bioregulator (Glu-Asp-Arg) that penetrates the DNA major groove to epigenetically regulate serotonin synthesis, preserve dendritic spine architecture, and activate endogenous antioxidant defenses against age-related neurodegeneration
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Oral (capsule/tablet)
Route
3 recommended
Sites
Multiple times daily
Frequency
Preparation
Bacteriostatic water (BAC water)
Insulin syringes (29-31 gauge)
Alcohol swabs
Sharps container
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
Mixing
Wash your hands thoroughly with soap and water. Gather all supplies on a clean, flat surface.
Remove the plastic cap from the peptide vial and wipe the rubber stopper with an alcohol swab. Let it air dry.
Draw the appropriate amount of bacteriostatic water into a sterile syringe.
Insert the needle into the vial at an angle, aiming at the inside wall of the vial. Slowly push the plunger to let the water trickle down the glass wall -- do NOT squirt directly onto the powder.
Once all water is added, gently swirl the vial in a slow circular motion. Never shake the vial, as this can damage the peptide bonds.
Continue swirling until the powder is completely dissolved and the solution is clear. If particles remain, let the vial sit for a few minutes and swirl again.
Label the vial with the date of reconstitution, the peptide name, and the concentration (e.g. 250mcg per 0.1mL).
Example calculation
If using a standard vial, add bacteriostatic water to achieve your desired concentration. For example, adding 2mL of BAC water to a vial allows precise dosing with an insulin syringe.
Dose calculation
Draw up the appropriate volume based on your reconstitution ratio. Consult dosing charts for exact volumes corresponding to 10-20 mg doses.
Pro tip
Always add the bacteriostatic water slowly, letting it run down the side of the vial. Never shake the vial -- swirl gently to avoid damaging the peptide.
Location
Site 01
Abdomen
Pinch the skin 2 inches from navel. Avoid the area directly around the belly button. Rotate between left and right sides.
Site 02
Outer Thigh
Middle third of the outer thigh. Keep at least 4 inches above the knee and below the hip. Alternate legs each injection.
Site 03
Upper Arm
Back or outer area of the upper arm. This site may require assistance from another person for proper technique.
Rotate between 3 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
Step by step
Wash hands and prepare clean workspace
Clean injection site with alcohol swab
Draw correct dose into insulin syringe
Pinch skin and insert needle at 45-90 degree angle
Inject slowly, withdraw needle
Apply gentle pressure—do not rub
Dispose of syringe in sharps container
Pro tip
This peptide uses subcutaneous injection (into the fatty tissue just under the skin). Inject at a 45-90 degree angle into pinched skin. Aspirate before injecting to ensure you haven't hit a blood vessel.
Timing
Optimal timing
Best time
Morning administration is generally preferred. Consistency matters more than the specific time of day.
With food?
Take on an empty stomach for optimal absorption.
Stacking notes
If combining Pinealon with other peptides, space administrations by 15-30 minutes. Consult your healthcare provider before combining with prescription medications.
Sample daily schedule
Morning (or as directed)
10-20 mg injection
Site: Rotate injection sites
Administer multiple times daily. Maintain consistency for optimal results.
Dosing tiers
Dose
1-2 mg
Frequency
Once daily
Duration
10-20 day cycle
Community-reported subcutaneous protocol used in practice. No human trials support this route; the injectable dose is community-derived [6].
Dose
0.2 mg
Frequency
Twice daily
Duration
20-30 days
Dose from a human clinical report in patients with cerebral asthenia after cranial trauma (n=72) [6]. A product/practice form uses a 10 mg capsule once or twice daily for a 10-30 day course, repeated 2-3 courses per year [6].
Preservation
Before mixing
Store in refrigerator at 36-46°F (2-8°C). Keep in original packaging to protect from light. Do not freeze.
After mixing
Store reconstituted solution in refrigerator at 36-46°F (2-8°C). Use within 30 days. Do not freeze reconstituted solution.
Shelf life after mixing
10 days refrigerated (solution form); capsules stable for 2-3 years in original packaging
Signs of degradation
Discard the vial immediately if you notice any of these:
Solution appears cloudy or discolored
Visible particles or precipitates in solution
Solution has changed color from original appearance
Vial has been exposed to temperatures above 77°F (25°C) for extended periods
Important
When to stop
Severe allergic reaction—difficulty breathing, significant swelling, or anaphylaxis
Persistent or worsening side effects that don't resolve with dose adjustment
Your healthcare provider recommends discontinuation
Pregnancy or planned pregnancy
Achievement of treatment goals (discuss maintenance protocol with provider)
Pinealon should only be used under the guidance of a qualified healthcare provider. This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, adjusting, or stopping any peptide protocol.
Clean technique checklist
Wash hands thoroughly with soap and water before handling supplies
Swab vial tops and injection site with alcohol and let dry
Never touch the needle tip or allow it to contact non-sterile surfaces
Use a new syringe and needle for each injection
Dispose of used sharps in a proper sharps container
Store reconstituted peptides according to the storage instructions above
Published research
Khavinson V, Linkova N, Kozhevnikova E, et al. · 2020
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Khavinson VKh, Lin'kova NS, Tarnovskaya SI, et al. · 2014
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Kraskovskaya NA, Kukanova EO, Lin'kova NS · 2017
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Silanteva IA, Komolkin AV, Morozova EA, et al. · 2019
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Mendzheritskiĭ AM, Karantysh GV, Ryzhak GA, et al. · 2014
This study investigated Pinealon, contributing to our understanding of its mechanism and therapeutic potential.
Khavinson et al. · 2021
Review summarizing a human cohort (n=72) with cerebral asthenia after cranial trauma given oral Pinealon 0.2 mg twice daily for 20-30 days, reporting improved cognitive and asthenic measures.
Head to head